Antiretroviral resistance among HIV-positive pregnant women who have antiretroviral experience from previous pregnancy

AIDS

Volumn 19, Issue 13, 2005, Pages 1439-

  Overton, Edgar T ^a   Sungkanuparph, Somnuek ^a   Nurutdinova, Diana ^a   Powderly, William G ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ANTIBIOTIC RESISTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GENE MUTATION; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 29144452190     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000180796.56640.5c     Document Type: Letter

References (3)

1. Lyons FE, Coughlan S, Byrne CM, Hopkins SM, Hall WW, Mulcahy FM. Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy. AIDS 2005; 19:63-67.
2. Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Bowonwatanuwong C, Kantipong P, Leechanachai P, et al. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004; 35:229-240.
3. Chaix ML, Dabis F, Ekouevi D, Rouet F, Tonwe-Gold B, Viho I, et al. Addition of 3 days of ZDV+3TC postpartum to a short course of ZDV+3TC and single-dose NVP provides low rate of NVP resistance mutations and high efficacy in preventing peripartum HIV-1 transmission: ANRS DITRAME Plus, Abidjan, Côte d'Ivoire. In: 12th Conference on Retroviruses and Opportunistic Infections. Boston, February 2005 [Abstract 72LB].